TDAY:NYSEUSA TODAY Co., Inc. Analysis
Data as of 2026-09-01 - not real-time
$6.29
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
USA TODAY Co., Inc. is priced at $6.29, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 25.3%. RSI sits at 27.2, which reads as oversold, and MACD momentum is bearish. The recent range runs from support at $6.16 up to resistance at $9.21.
On valuation the read is fair — earnings multiple of 18.5 versus a 16.1 sector average, above the peer group. Consensus targets land 38.3% above where the shares trade now. Revenue is contracting at 8.3% on a -1.8% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 50.1%, a beta of 0.36 and a maximum drawdown of 30.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: sell, at a conviction of 5 out of 10.
On valuation the read is fair — earnings multiple of 18.5 versus a 16.1 sector average, above the peer group. Consensus targets land 38.3% above where the shares trade now. Revenue is contracting at 8.3% on a -1.8% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 50.1%, a beta of 0.36 and a maximum drawdown of 30.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: sell, at a conviction of 5 out of 10.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- RSI at 27.2 signals oversold conditions
- Trading below the 200-day average of 6.76
- MACD momentum is negative
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- RSI at 27.2 signals oversold conditions
- P/E of 18.5 versus sector average of 16.1
- Trading below the 200-day average of 6.76
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- P/E of 18.5 versus sector average of 16.1
- Negative profit margin of -1.8%
- Analyst targets imply +38.3% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-8.30%
Profit Margin-1.81%
P/E Ratio18.5
ROE-20.66%
ROA4.76%
Debt/Equity725.56
P/B Ratio6.5
Op. Cash Flow$113.2M
Free Cash Flow$84.6M
Industry P/E16.1
Technical Analysis
TrendNeutral
RSI27.2
Support$6.16
Resistance$9.21
MA 20$6.98
MA 50$7.89
MA 200$6.76
MACDBearish
VolumeDecreasing
Fear & Greed Index92.93
Valuation
Fair Value$0.35
Target Price$8.70
Upside/Downside38.31%
GradeFair
TypeBlend
Risk Assessment
Beta0.36
Volatility50.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.